Int J Proteomics. 2012;2012:342659. doi: 10.1155/2012/342659. Epub 2012 Aug 08.

Human myocardial protein pattern reveals cardiac diseases.

International journal of proteomics

Jonas Bergquist, Gökhan Baykut, Maria Bergquist, Matthias Witt, Franz-Josef Mayer, Doan Baykut

PMID: 22928107 PMCID: PMC3423942 DOI: 10.1155/2012/342659

Abstract

Proteomic profiles of myocardial tissue in two different etiologies of heart failure were investigated using high performance liquid chromatography (HPLC)/Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS). Right atrial appendages from 10 patients with hemodynamically significant isolated aortic valve disease and from 10 patients with isolated symptomatic coronary heart disease were collected during elective cardiac surgery. As presented in an earlier study by our group (Baykut et al., 2006), both disease forms showed clearly different pattern distribution characteristics. Interesting enough, the classification patterns could be used for correctly sorting unknown test samples in their correct categories. However, in order to fully exploit and also validate these findings there is a definite need for unambiguous identification of the differences between different etiologies at molecular level. In this study, samples representative for the aortic valve disease and coronary heart disease were prepared, tryptically digested, and analyzed using an FT-ICR MS that allowed collision-induced dissociation (CID) of selected classifier masses. By using the fragment spectra, proteins were identified by database searches. For comparison and further validation, classifier masses were also fragmented and analyzed using HPLC-/Matrix-assisted laser desorption ionization (MALDI) time-of-flight/time-of-flight (TOF/TOF) mass spectrometry. Desmin and lumican precursor were examples of proteins found in aortic samples at higher abundances than in coronary samples. Similarly, adenylate kinase isoenzyme was found in coronary samples at a higher abundance. The described methodology could also be feasible in search for specific biomarkers in plasma or serum for diagnostic purposes.

References

1. J Proteome Res. 2011 Sep 2;10(9):4054-65 - PubMed
2. Eur J Med Res. 2006 Jun 30;11(6):221-6 - PubMed
3. Curr Opin Mol Ther. 2003 Jun;5(3):310-4 - PubMed
4. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10449-53 - PubMed
5. Mol Med Rep. 2011 Jul-Aug;4(4):655-61 - PubMed
6. Circ Res. 2003 Nov 14;93(10):998-1005 - PubMed
7. J Proteome Res. 2003 Jul-Aug;2(4):383-93 - PubMed
8. Proteomics. 2004 Dec;4(12):4010-8 - PubMed
9. Mol Genet Metab. 2000 Sep-Oct;71(1-2):445-50 - PubMed
10. Eur J Biochem. 1991 Dec 18;202(3):775-81 - PubMed
11. Anal Bioanal Chem. 2003 Aug;376(7):952-65 - PubMed
12. J Mass Spectrom. 2006 Jun;41(6):705-16 - PubMed
13. Expert Rev Proteomics. 2009 Aug;6(4):395-409 - PubMed
14. Proteomics Clin Appl. 2011 Feb;5(1-2):57-66 - PubMed
15. Circulation. 1997 Nov 18;96(10):3466-76 - PubMed
16. Circ Res. 2011 Aug 5;109(4):463-74 - PubMed
17. J Proteome Res. 2006 Sep;5(9):2364-71 - PubMed
18. Am J Cardiol. 1975 May;35(5):725-39 - PubMed
19. Mass Spectrom Rev. 2002 Jan-Feb;21(1):2-15 - PubMed
20. Mol Cell Neurosci. 2003 Apr;22(4):544-54 - PubMed
21. N Engl J Med. 2005 Apr 21;352(16):1685-95 - PubMed
22. Mol Cell Proteomics. 2011 Apr;10(4):M110.003517 - PubMed
23. Curr Biol. 1993 Jun 1;3(6):327-32 - PubMed

Publication Types

• Journal Article